{"database": "lobbying", "table": "lobbying_activities", "rows": [[673839, "5702c24e-e0fa-44d6-8853-07cdaac0664d", "Q3", "RASKY PARTNERS, INC.", 297410, "ELI LILLY AND CO", 2008, "third_quarter", "PHA", "HR 5629, Pathway for Biosimilars Act Legislation", "HOUSE OF REPRESENTATIVES,SENATE", 30000, null, 0, 0, "2008-10-17T11:57:03-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["673839"], "units": {}, "query_ms": 10.058618965558708, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}